Skip to main content

Table 1 Reported cases of primary plasmacytoma with multiple lymph node involvement

From: Primary extramedullary plasmacytoma with diffuse lymph node involvement: a case report and review of the literature

Author/reference

Patient age/sex

Lymph nodes involved

Ig isotype

Serum monoclonal protein

Bone marrow involvement

Initial therapy

Response to initial therapy

Relapse or persistent disease

Additional therapy

Survival

Salem et al. [16]

48 M

Paratracheal, precarinal, subcarinal, aortopulmonary

IgG λ

M-Spike 2.1 g/dL, λ FLC 1613 mg/L

None

Involved field radiation (50 Gy in 25 fractions)

No response

Persistent disease following first-line radiation

VTD-PACE, then auto SCT, then lenalidomide maintenance

In CR 18 months following auto-SCT

Matsushima et al. [17]

56 F

Mandibular, cervical, axillary, para-aortic

IgA K

Present, though not quantified

None

Cyclophosphamide and prednisolone (10 courses)

Complete response (CR)

Relapse 6 years following initial CR

Melphalan and prednisolone (10C)

In CR 9 years following initial diagnosis

Gorodetskiy et al. [18]

48 F

Diffuse LAD, most prominent at supraclavicular, femoral nodes

IgA K

M-Spike 7.2 g/dL

None

CHOP for 9 cycles

Complete response (CR)

Relapse at 3 months and again at 19 months

Initial relapse treated with 1C CEVD, subsequent treated with 1C CHOEP

In CR 18 years following initial diagnosis

Menke et al. [6]

Not specified

“Disseminated LN involvement”, specific sites unspecified

Not specified

Not specified

None

Chlorambucil for 8 weeks

Complete response (CR)

None

None

In CR 3 years following initial diagnosis

Menke et al. [6]

Not specified

“Disseminated LN involvement”, specific sites unspecified

Not specified

Not specified

None

Chlorambucil and prednisone for 8 weeks

No response

Persistent disease following first-line therapy

None

Died of disease 2 months following diagnosis

Lim et al. [19]

56 M

Right submental and submandibular

IgG λ

M-Spike 1.6 g/dL

None

Involved field radiation (50 Gy in 25 fractions)

Incompletely reported

Residual mass of uncertain viability to be monitored with serial PET

None

Duration of survival not reported

Lin et al. [20]

58 F

Bilateral cervical

K light chain

Present, though not quantified

None

Excision

Complete response (CR)

None

None

In CR at 1 year following excision

  1. Seven cases of primary plasmacytoma involving multiple lymph nodes are reported in the literature. Two of these cases (Lim et al. and Lin et al.) were localized enough to be treated via surgery or radiation alone. Thus, only five cases describe disease sufficiently disseminated as to require systemic chemotherapy
  2. Abbreviations: C cycle, CEVD lomustine, etoposide, vinblastine, dexamethasone, CHOP doxorubicin, cyclophosphamide, vincristine, prednisolone, CHOEP doxorubicin, cyclophosphamide, vincristine, etoposide, prednisolone, CR complete remission, F female, FLC free light chain, LAD lymphadenopathy, LN lymph node, M male, M-Spike monoclonal spike, PET positron emission tomography, SCT stem cell transplantation,VTD-PACE dexamethasone, thalidomide, cisplatin, doxorubicin, cyclophosphamide, etoposide, bortezomib